Literature DB >> 32308102

Downregulation of lncRNA BACE1-AS improves dopamine-dependent oxidative stress in rats with Parkinson's disease by upregulating microRNA-34b-5p and downregulating BACE1.

Yanhong Li1, Jian Fang1, Zhanye Zhou2, Qiyu Zhou3, Shibin Sun2, Zhikai Jin2, Ziming Xi1, Jianshe Wei4.   

Abstract

Objective: Long noncoding RNAs (lncRNAs) have already been proposed to function in Parkinson's disease (PD). However, the role of lncRNA BACE1-AS in PD has never been discussed. This study aims to examine the mechanism of BACE1-AS on oxidative stress injury of dopaminergic neurons in PD rats.
Methods: Rat models of PD were established through the injection of 6-hydroxydopamine. The rotation of rats was induced by intraperitoneal injection of apomorphine, and number of rotations per minute was detected. The levels of malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px), glutamic acid (Glu), dopamine (DA), tyrosine hydroxylase (TH), α-synuclein and inducible nitric oxide synthase (iNOS) in the substantia nigra of rats in each group were detected. Apoptosis and pathological changes in the substantia nigra were also observed. BACE1-AS, miR-34b-5p, BACE1, Bax and Bcl-2 expression in the substantia nigra were detected. The binding of BACE1-AS and miR-34b-5p and the targeting relationship of miR-34b-5p and BACE1 were further determined.
Results: Downregulated BACE1-AS reduced iNOS, α-synuclein and Glu levels and elevated DA and TH levels in the substantia nigra of PD rats. Downregulated BACE1-AS repressed apoptosis and oxidative stress injury in the substantia nigra neurons of PD rats. BACE1-AS specifically bound to miR-34b-5p. BACE1 was a direct target gene of miR-34b-5p.
Conclusion: Collectively, our study reveals that downregulation of lncRNA BACE1-AS inhibits iNOS activation in the substantial nigra and improve oxidative stress injury in PD rats by upregulating miR-34b-5p and downregulating BACE1.

Entities:  

Keywords:  BACE1; Long noncoding RNA BACE1-AS; MicroRNA-34b-5p; Parkinson’s disease; dopaminergic neurons; iNOS

Year:  2020        PMID: 32308102      PMCID: PMC7217373          DOI: 10.1080/15384101.2020.1749447

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  32 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Genome regulation by long noncoding RNAs.

Authors:  John L Rinn; Howard Y Chang
Journal:  Annu Rev Biochem       Date:  2012       Impact factor: 23.643

3.  Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease.

Authors:  M Decressac; B Mattsson; A Björklund
Journal:  Exp Neurol       Date:  2012-02-25       Impact factor: 5.330

4.  Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson's disease in rats.

Authors:  Xiaorong Pan; Chunxia Chen; Jianping Huang; Haiming Wei; Qiuping Fan
Journal:  Neurosci Lett       Date:  2015-06-20       Impact factor: 3.046

5.  Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2.

Authors:  C Knott; G Stern; G P Wilkin
Journal:  Mol Cell Neurosci       Date:  2000-12       Impact factor: 4.314

6.  The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease.

Authors:  Marong Fang; Jing Wang; Xiaobing Zhang; Yu Geng; Zhiying Hu; John A Rudd; Shucai Ling; Wei Chen; Shu Han
Journal:  Toxicol Lett       Date:  2011-12-08       Impact factor: 4.372

Review 7.  Diagnosis and Management of Parkinson's Disease.

Authors:  Arjun Tarakad; Joseph Jankovic
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

8.  Long Non-coding RNA HOTAIR Promotes Parkinson's Disease Induced by MPTP Through up-regulating the Expression of LRRK2.

Authors:  Sen Liu; Bei Cui; Zhen-xia Dai; Peng-ke Shi; Zhao-hui Wang; Yuan-yuan Guo
Journal:  Curr Neurovasc Res       Date:  2016       Impact factor: 1.990

9.  MicroRNA-21 promotes cell growth and migration by targeting programmed cell death 4 gene in Kazakh's esophageal squamous cell carcinoma.

Authors:  Tao Liu; Qing Liu; Shutao Zheng; Xiangpeng Gao; Mang Lu; Chenchen Yang; Fang Dai; Ilyar Sheyhidin; Xiaomei Lu
Journal:  Dis Markers       Date:  2014-10-21       Impact factor: 3.434

10.  Aberrantly expressed long noncoding RNAs and genes in Parkinson's disease.

Authors:  Yong Zhou; Chengzhi Gu; Jia Li; Lianhai Zhu; Guoxiang Huang; Jie Dai; Huaiyu Huang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-11-22       Impact factor: 2.570

View more
  11 in total

1.  Clinical significance and biological effect of ZFAS1 in Hirschsprung's disease and preliminary exploration of its underlying mechanisms using integrated bioinformatics analysis.

Authors:  Yujiao Wang; Peng Cai; Jian Wang
Journal:  Ir J Med Sci       Date:  2022-01-06       Impact factor: 1.568

Review 2.  Crosstalk of Astrocytes and Other Cells during Ischemic Stroke.

Authors:  Tingting He; Guo-Yuan Yang; Zhijun Zhang
Journal:  Life (Basel)       Date:  2022-06-17

3.  Long noncoding RNA BACE1-antisense transcript plays a critical role in Parkinson's disease via microRNA-214-3p/Cell death-inducing p53-target protein 1 axis.

Authors:  Lina Li; Hongjuan Wang; Huicang Li; Xin Lu; Yanxiang Gao; Xiaofeng Guo
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

4.  Berberine Suppresses Mice Depression Behaviors and Promotes Hippocampal Neurons Growth Through Regulating the miR-34b-5p/miR-470-5p/BDNF Axis.

Authors:  Yuhua Zhan; Jiyang Han; Jing Xia; Xumei Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-22       Impact factor: 2.570

Review 5.  The Role of Non-Coding RNAs in the Neuroprotective Effects of Glutathione.

Authors:  Chisato Kinoshita; Koji Aoyama
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

Review 6.  The Emerging Roles of the β-Secretase BACE1 and the Long Non-coding RNA BACE1-AS in Human Diseases: A Focus on Neurodegenerative Diseases and Cancer.

Authors:  Arezou Sayad; Sajad Najafi; Bashdar Mahmud Hussen; Sara Tharwat Abdullah; Ahmad Movahedpour; Mohammad Taheri; Mohammadreza Hajiesmaeili
Journal:  Front Aging Neurosci       Date:  2022-03-21       Impact factor: 5.750

7.  LncRNA miR-17-92a-1 cluster host gene (MIR17HG) promotes neuronal damage and microglial activation by targeting the microRNA-153-3p/alpha-synuclein axis in Parkinson's disease.

Authors:  Jianzhong Zhang; Yun Yang; Chaoyang Zhou; Ronglan Zhu; Xiang Xiao; Bin Zhou; Dengfeng Wan
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

Review 8.  Crosstalk between regulatory non-coding RNAs and oxidative stress in Parkinson's disease.

Authors:  Hantao Zhang; Xiaoyan Liu; Yi Liu; Junlin Liu; Xun Gong; Gang Li; Min Tang
Journal:  Front Aging Neurosci       Date:  2022-08-09       Impact factor: 5.702

9.  Microarray Profiling Reveals Distinct Circulating miRNAs in Aged Male and Female Mice Subjected to Post-stroke Social Isolation.

Authors:  Anik Banerjee; Anil K Chokkalla; Julia J Shi; Juneyoung Lee; Venugopal Reddy Venna; Raghu Vemuganti; Louise D McCullough
Journal:  Neuromolecular Med       Date:  2020-10-19       Impact factor: 4.103

Review 10.  Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson's Disease.

Authors:  Shubhra Acharya; Antonio Salgado-Somoza; Francesca Maria Stefanizzi; Andrew I Lumley; Lu Zhang; Enrico Glaab; Patrick May; Yvan Devaux
Journal:  Int J Mol Sci       Date:  2020-09-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.